*A Wills Eye affiliation search function was used in PubMed to populate the list below. Any manuscripts published in October 2021 under a different affiliation and/or not present on PubMed were not included in this list.
CORNEA
Raber IM, Eagle RC Jr. Peripheral Hypertrophic Subepithelial Corneal Degeneration. Cornea. 2021 Oct 6. doi: 10.1097/ICO.0000000000002716. Epub ahead of print. PMID: 34620763. https://pubmed.ncbi.nlm.nih.gov/34620763/
Parker JS, Dockery PW, Jacob S, Parker JS. Preimplantation dehydration for corneal allogenic intrastromal ring segment implantation. J Cataract Refract Surg. 2021 Nov 1;47(11):e37-e39. doi: 10.1097/j.jcrs.0000000000000582. PMID: 34675164. https://pubmed.ncbi.nlm.nih.gov/34675164/
GLAUCOMA
Ganjei AY, Shalaby WS, Wu C, Al-Aswad LA, Myers JS, Shukla AG. Descriptive Analysis of United States Glaucoma Fellowship Program Directors. Ophthalmol Glaucoma. 2021 Oct 13:S2589-4196(21)00239-8. doi: 10.1016/j.ogla.2021.10.004. Epub ahead of print. PMID: 34655798. https://pubmed.ncbi.nlm.nih.gov/34655798/
Shalaby WS, Arbabi A, Myers JS, Moster MR, Razeghinejad R, Katz LJ, Shukla AG. Sociodemographic and Economic Factors in Outcomes of Tube Shunts for Neovascular Glaucoma. J Curr Glaucoma Pract. 2021;15(2):70-77. doi: 10.5005/jp-journals-10078-1303. PMID: 34720496; PMCID: PMC8543744. https://pubmed.ncbi.nlm.nih.gov/34720496/
OCULAR ONCOLOGY
Sen M, Honavar SG. Wilhelm Conrad Röntgen: Finding X. Indian J Ophthalmol. 2021 Oct;69(10):2570-2572. doi: 10.4103/ijo.IJO_2321_21. PMID: 34571595. https://pubmed.ncbi.nlm.nih.gov/34571595/
RETINA
Hinkle JW, Mahmoudzadeh R, Kuriyan AE. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics. Stem Cell Res Ther. 2021 Oct 11;12(1):538. doi: 10.1186/s13287-021-02546-9. PMID: 34635174; PMCID: PMC8504041. https://pubmed.ncbi.nlm.nih.gov/34635174/
Mahmoudzadeh R, Israilevich R, Salabati M, Hsu J, Garg SJ, Regillo CD, Ho AC, Khan MA. Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane: Optical Coherence Tomography Biomarkers of Visual Outcomes in 322 Eyes. Ophthalmol Retina. 2021 Oct 27:S2468-6530(21)00335-3. doi: 10.1016/j.oret.2021.10.008. Epub ahead of print. PMID: 34718218. https://pubmed.ncbi.nlm.nih.gov/34718218/
Pulido JS, Procopio R, Davila HJ, Bello N, Ku C, Pennesi ME, Yang P, Nagiel A, Mahroo OA, Aleman TS, Salido EM, Reynolds M. IRD panels-caveat emptor-truly know your IRD panel. Retina. 2021 Oct 14. doi: 10.1097/IAE.0000000000003319. Epub ahead of print. PMID: 34690342. https://pubmed.ncbi.nlm.nih.gov/34690342/
Sharma A, Kumar N, Parachuri N, Karanam D, Kuppermann BD, Bandello F, Regillo CD. Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials. Eye (Lond). 2021 Oct 30. doi: 10.1038/s41433-021-01831-4. Epub ahead of print. PMID: 34718339. https://pubmed.ncbi.nlm.nih.gov/34718339/